PLoS ONE (Jan 2013)

Endo-MitoEGFP mice: a novel transgenic mouse with fluorescently marked mitochondria in microvascular endothelial cells.

  • Sarah Pickles,
  • Maxime Cadieux-Dion,
  • Jorge I Alvarez,
  • Marc-Andre Lécuyer,
  • Sarah L Peyrard,
  • Laurie Destroismaisons,
  • Lydia St-Onge,
  • Simone Terouz,
  • Patrick Cossette,
  • Alexandre Prat,
  • Christine Vande Velde

DOI
https://doi.org/10.1371/journal.pone.0074603
Journal volume & issue
Vol. 8, no. 9
p. e74603

Abstract

Read online

Blood vessel-specific fluorescent transgenic mice are excellent tools to study the development of the vasculature and angiogenic processes. There is growing interest in the biological processes relevant to endothelial cells but limited tools exist to selectively evaluate subcellular functions of this cell type in vivo. Here, we report a novel transgenic animal model that expresses mitochondrially targeted enhanced green fluorescent protein (EGFP) via the Hb9 promoter, a homeobox transcription factor with limited known involvement in the vasculature. Random integration of the transgene, containing the entire mouse Hb9 promoter, was found to be expressed in a variety of vascularised tissues. Further inspection revealed that Mito-EGFP localizes to the endothelial cells (ECs) of a subset of microvascular blood vessels, especially in the central nervous system (CNS), heart, spleen, thymus, lymph nodes and skin. We demonstrate the utility of this novel transgenic mouse, named Endo-MitoEGFP, in the detection, imaging, and isolation of microvascular ECs and evaluation of EC mitochondrial function isolated from adult animals. These transgenic mice will be useful to studies of ECs in development, physiology, and pathology.